Ubiquitination of IκBα requires the Nedd8 pathway. (A) Reconstitution of IκBα ubiquitination activity in vitro. Ubiquitination assays were performed with HeLa FII (40 μg), ubiquitin (60 μM), an ATP-regenerating system, and recombinant 35S-labeled IκBα/p652 phosphorylated on S32 and S36 as described in the text. Into these reactions, HeLa FI (15 μg), UbcH5A (150 nM), Nedd8 (250 nM), and WT Ubc12 (150 nM) or Ubc12C111S (5 μM) was added as indicated. Following incubation at 37°C for 0 or 90 min, reactions were stopped by the addition of SDS sample buffer and resolved on an SDS–9% gel, and the reaction products were detected with a phosphorimager. (B) Ubc12C111S acts as a dominant negative inhibitor of IκBα ubiquitination. Reactions were performed as for panel A, using FII (40 μg), ubiquitin (60 μM), UbcH5A (150 nM), Nedd8 (1 μM), an ATP-regenerating system, and recombinant 35S-labeled IκBα/p652 phosphorylated on S32 and S36 as described in the text. Into these reactions, WT Ubc12 was added at 50 nM (lanes 1, 2 and 4), 500 nM (lane 5), or 1 μM (lane 6). Ubc12C111S (Ubc12 C-5; 5 μM) was added in lanes 3 to 6. Following incubation at 37°C for 0 or 90 min, reactions were stopped by the addition of SDS sample buffer and resolved on an SDS–9% gel, and the reaction products were detected with a phosphorimager.